3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Breast Neoplasms
9
Neoplasms
6
Anxiety Disorders
6
Depression
3
Ovarian Neoplasms
2
Head and Neck Neoplasms
2
Chronic Pain
2
Vomiting
1
Uterine Cervical Neoplasms
1
Testicular Germ Cell Tumor
1
Tendinopathy
1
Smoking Cessation
1
Sleep Wake Disorders
1
Sarcoma
1
Radiculopathy
1
Pulmonary Disease, Chronic Obstructive
1
Prostatic Neoplasms
1
Pathophobia
1
Pain, Postoperative
1
Pain
1
Nociceptive Pain
1
Neuralgia, Postherpetic
1
Neuralgia
1
Nausea
1
Myocarditis
1
Musculoskeletal Pain
1
Melanoma
1
Medication Adherence
1
Lung Diseases, Interstitial
1
Leukemia, Myeloid, Acute
1
Interventions
Blood Specimen Collection
11
Radiosurgery
7
Sentinel Lymph Node Biopsy
5
Early Intervention, Educational
5
Surveys and Questionnaires
4
Standard of Care
4
Practice Guidelines as Topic
4
Methods
4
Indocyanine Green
4
Educational Status
4
X-Rays
3
Surgical Procedures, Operative
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Ipilimumab
3
Immunotherapy
3
Cognitive Behavioral Therapy
3
Biopsy
3
pembrolizumab
2
montanide ISA 51
2
aldesleukin
2
Tomography, X-Ray Computed
2
Tomography, Emission-Computed
2
Specimen Handling
2
Radiotherapy
2
Radiation
2
Positron-Emission Tomography
2
Palliative Care
2
Observation
2
Interviews as Topic
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Melanoma
×
Hypnosis
×
Clear all
NCT04899492
2024-11-07
RESPIRE
Institut Cancerologie de l'Ouest
Phase NA
Terminated
22 enrolled